ADBP 5F ADB Pharmaceutical Intermediates , ADB - PINACA AB - FUBINACA White Powder

adbf white powder adbp 5fadb adb-f  abf ADB-F-UBINACA ADB-PINACA AB-FUBINACA

Quick Details

MDMB-CHMICA(also incorrectly known asMMB-CHMINACA) is anbased that is a potent of the tor and has been sold online While MDMB-CHMICA was initially sold under the name "MMB-CHMINACA", the compound corresponding to this code name (i.e. the isopropyl instead of t-butyl analogue of has been identified on the designer drug market in 2015 as amb-chminaca

5F-AB-PINACAis anthat is derived from a series of compounds originally developed by in 2009 as medication, and has been sold online

5F-AB-PINACA has been reported to be a potent of the andwith values of 0.48 nM and 2.6 nM respectively.Its metabolism has been described in literature.

U-50488is a drug which acts as a highly selective , but without any effects. It has cand effects,and reverses the memory impairment produced by drugs. U-50488 was one of the first selective kappa agonists invented and research on its derivatives has led to the development of a large family of related compounds

3-Methoxyeticyclidine(3-MeO-PCE) is that is qualitatively similar to PCE AND PCP and has been sold online as

4-Methoxyphencyclidine(methoxydine,4-MeO-PCP) is a drug that has been sold online as a The synthesis of 4-MeO-PCP was first reported in 1965 by the medicinal chemist Victor Maddox.A 1999 review published by a chemist using the pseudonym John Q. Beagle suggested the potency of 4-MeO-PCP in man was reduced relative to PCP, two years later Beagle published a detailed description of the synthesis and qualitative effects of 4-MeO-PCP,

Methaqualone, sold under the brand nameQuaaludein the US andMandraxin the UK and South Africa, is medication. It is a member of the e class.

The sedative–hypnotic activity of methaqualone was first noted by researchers in the 1950s. In 1962, methaqualone was patented in the US by Wallace and Tiernan. Its use peaked in the early 1970s as a or the treatment.

related to It possesses structural similarity to several and has as a
It is used for treatment of acute attacks (sometimes in combination with Medicinal usage of ergot fungus began in the 16th century to induce yet dosage uncertainties discouraged the use. It has been used to prevent (bleeding after childbirth). It was first isolated from the ergot fungus and marketed as Gynergen in 1921
N-Ethylhexedrone(also known asα-ethylaminocaprophenone,N-ethylnorhexedrone,hexenandNEH) is of the classN-Ethylhexedrone was first mentioned in a series of patents by in the 1960s which lead to the development of the better known drug (MDPV). Since the mid-2010s, N-ethylhexedrone has been sold online

Fuambai Sia Ahmadu(born c. 1969 is a Sierra Leonean-American anthropologist. She has worked for and the Britishlin the Gambia.

Ahmadu obtained her PhD in social anthropology from the and undertook post-doctoral work at the Department of Comparative Human Development,

FUF
Fentanyl provides some of the effects typical of other opioids through its agonism of the . Its strong potency in relation to that of morphine is largely due to its highper the Because of this, it can more easily penetrate the

BROMADOLINE is the same effect with u-47700

Alprazolam is mostly used to treat and due to The FDA label advises that the physician should periodically reassess the usefulness of the drug. Alprazolam may also be indicated for the treatment of generalized anxiety disorder, as well as for the treatment of anxiety conditions with co-morbid depression. Alprazolam is also often prescribed with instances co-morbid sleep deficits.

α-PVP, like other psychostimulants, can cause hyperstimulation, paranoia, and hallucinations. α-PVP has been reported to be the cause, or a significant contributory cause of death in suicides and overdoses caused by combinations of drugs. α-PVP has also been linked to at least one death where it was combined with and caused